Skip to main content
Press Room
Public Policy
Share
Languages
English
Español
X
Search
Donate
Email Sign Up
About
Our Organization
Staff & Board
Careers
Frequently Asked Questions
Contact Us
Volunteer Leadership Affinity Groups
Our Work
Reducing Health Disparities
Where We Work
Annual Reports & Financials
Judicial Advocacy Initiative
Priorities
Access to Healthcare
Access to Health Insurance
Health Insurance Affordability
Increasing and Protecting Access to Medicaid
Access to Biomarker Testing
Cancer Prevention
Breast and Cervical Cancer
Prostate Cancer
Colorectal Cancer
Multi-Cancer Early Detection Tests
Healthy Eating and Active Living
Cancer Research
Cancer Research Funding
Clinical Trials
Childhood Cancer Research
Voices of Cancer Research
Quality of Life
Palliative Care
Tobacco Control
Tobacco Regulation and Products
Smoke-Free
Prevention and Cessation
Tobacco Taxes
Support Our Work
Donate
Make a Donation
Honor a Loved One
Donate by Mail
ACS CAN store
Raise Money
Create my own event
Honor or Memorial
Volunteer Fundraising Toolkit
Membership
Join
Membership Benefits
Take Action
Add Your Voice
Get Updates and Action Opportunities
Volunteer in your Community
Share Your Story
Survivor Views
Fundraise
Lights of Hope
Cancer Votes
College Advocacy
Attend Events
Select a State
My State
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District Of Columbia
Florida
Georgia
Guam
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Puerto Rico
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
Go
Table A-5 Part 3: New cancer drugs approved 2016–2025 and associated PREA and BPCA activity
Share
Download Image
